History and outcome of febrile neutropenia related to non-chemotherapy drugs: A retrospective study of the Strasbourg's agranulocytosis cohort

Published:August 17, 2017DOI:
      Despite major advances in prevention and treatment, febrile neutropenia (absolute neutrophil count <0.5 × 10(9)/L) remains one of the most concerning complications of cancer chemotherapy, especially in patients receiving myelosuppressive chemotherapy [
      • Lustberg M.B.
      Management of neutropenia in cancer patients.
      ]. Outside the context of Oncology, few data are currently available for febrile neutropenia, especially for febrile neutropenia related to non-chemotherapy drugs, called “idiosyncratic agranulocytosis”.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Lustberg M.B.
        Management of neutropenia in cancer patients.
        Clin Adv Hematol Oncol. 2012; 10: 825-826
        • Klastersky J.
        • de Naurois J.
        • Rolston K.
        • Rapoport B.
        • Maschmeyer G.
        • Aapro M.
        • et al.
        Management of febrile neutropaenia: ESMO clinical practice guidelines.
        Ann Oncol. 2016; 27: 111-118
        • Andrès E.
        • Zimmer J.
        • Mecili M.
        • Weitten T.
        • Alt M.
        Clinical presentation and management of drug-induced agranulocytosis.
        Expert Rev Hematol. 2011; 4: 143-151
        • Andrès E.
        • Maloisel F.
        • Kurtz J.E.
        • Kaltenbach G.
        • Alt M.
        • Weber J.C.
        • et al.
        Modern management of non-chemotherapy drug-induced agranulocytosis: a monocentric cohort study of 90 cases and review of the literature.
        Eur J Intern Med. 2002; 13: 324-328
        • Maloisel F.
        • Andrès E.
        • Kaltenbach G.
        • Noel E.
        Prognostic factors of hematological recovery in nonchemotherapy drug-induced agranulocytosis.
        Haematologica. 2003; 88: 470-471
        • Andersohn F.
        • Konzen C.
        • Garbe E.
        Non-chemotherapy drug-induced agranulocytosis: a systematic review of case reports.
        Ann Intern Med. 2007; 146: 657-665